Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab.
Ann Hematol
; 100(8): 2117-2119, 2021 Aug.
Article
in En
| MEDLINE
| ID: mdl-32856142
Full text:
1
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyrimidines
/
Skin Neoplasms
/
Carcinoma, Squamous Cell
/
Primary Myelofibrosis
/
Antibodies, Monoclonal, Humanized
/
Antineoplastic Agents
/
Nitriles
Type of study:
Risk_factors_studies
Limits:
Aged
/
Humans
/
Male
Language:
En
Year:
2021
Type:
Article